Literature DB >> 1722090

Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.

N Kobayashi1, K Taniguchi, T Urasawa, S Urasawa.   

Abstract

For selecting the neutralizing monoclonal antibodies (N-MAbs) directed to VP4 of rotavirus strain K8, which has unique VP4 neutralization epitopes, we prepared several reassortant viruses by mixed infection of two different strains K8 (serotype 1) and P (serotype 3) in vitro: three reassortant clones having VP4 of K8 and VP7 of P and four clones having VP4 of P and VP7 of K8. By using these reassortants in screening hybridomas, a N-MAb (K8-2C12) directed to strain K8-specific VP4 was obtained. The MAb K8-2C12 neutralized only K8 when tested against numerous strains of different serotypes, while in enzyme-linked immunosorbent assay this MAb reacted also with simian rotavirus SA11 (serotype 3), bovine rotavirus NCDV (serotype 6), and human rotavirus (HRV) strain 69M (serotype 8). Neutralization-resistant mutants of K8 were selected by the K8-2C12 antibody and VP4 amino acid sequences of the mutants were determined. Single amino acid substitution was detected in the three mutant clones at position 394, which is included in the major cross-reactive neutralization region identified in other rotaviruses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722090     DOI: 10.1007/bf01316751

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

Authors:  N Kobayashi; K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Validity of an enzyme-linked immunosorbent assay with serotype-specific monoclonal antibodies for serotyping human rotavirus in stool specimens.

Authors:  S Urasawa; T Urasawa; K Taniguchi; Y Morita; N Sakurada; Y Saeki; O Morita; S Hasegawa
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

3.  The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.

Authors:  E R Mackow; R D Shaw; S M Matsui; P T Vo; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.

Authors:  K Taniguchi; S Urasawa; T Urasawa
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

5.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.

Authors:  K Taniguchi; W L Maloy; K Nishikawa; K Y Green; Y Hoshino; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes.

Authors:  K Taniguchi; K Nishikawa; T Urasawa; S Urasawa; K Midthun; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.

Authors:  Y Morita; K Taniguchi; T Urasawa; S Urasawa
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

8.  Use of transcription probes for genotyping rotavirus reassortants.

Authors:  J Flores; H B Greenberg; J Myslinski; A R Kalica; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

9.  Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.

Authors:  R L Ward; D R Knowlton; G M Schiff; Y Hoshino; H B Greenberg
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Sequential passages of human rotavirus in MA-104 cells.

Authors:  T Urasawa; S Urasawa; K Taniguchi
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  6 in total

1.  Serologic and genomic characterization of a G12 human rotavirus in Thailand.

Authors:  M Wakuda; S Nagashima; N Kobayashi; Y Pongsuwanna; K Taniguchi
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Human rotavirus strain with unique VP4 neutralization epitopes as a result of natural reassortment between members of the AU-1 and Wa genogroups.

Authors:  O Nakagomi; E Kaga; T Nakagomi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells.

Authors:  J Lee; L A Babiuk; D Yoo
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

4.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

5.  Human rotavirus K8 strain represents a new VP4 serotype.

Authors:  B Li; G Larralde; M Gorziglia
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Characterization of human rotavirus strains causing gastroenteritis in Kenya.

Authors:  Z Gatheru; N Kobayashi; N Adachi; S Chiba; J Muli; P Ogaja; J Nyangao; E Kiplagat; P M Tukei
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.